Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering ...

At 2 p.m. Tuesday on my radio program, I said, “If Mike Tomlin had an ounce of pride, he’d quit.” Tomlin’s resignation broke a little over five minutes later. So it was said, so it did come to pass.

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is ...